American Premium Water Corp (HIPH)
 

Traders,

 

It’s time to get tuned in for an exciting week ahead, and what better way to start it off with a company that very few of our readers will have ever come across, yet this has the potential become one of the hottest tickers in the OTC.

Let’s get down to business. Tomorrow’s play is American Premium Water Corp (HIPH).

Why is HIPH our favorite to start the week? This company operates in the $15+ billion dollar bottled water industry – and their product is used and endorsed by many hot celebrities.

But as usual, let me start with technical’s which are equally exciting. The chart is stacking up perfectly for a major bounce higher.

As you can see in the chart there is major long term support at $0.01 – which is exactly where HIPH closed on Friday. In fact, it has only dipped below $0.01 briefly on one day out of the past six months.

HIPH pulled back from recent highs of $0.04 as some shareholders took gains after a 100% move higher in June.

Now it looks like a perfect bounce play opportunity.

With a stop just below the long term support of $0.01, and the potential to regain the 50 or 100 day moving average of around $0.0275 – 0.03 – or even a breakout through the recent highs of $0.04 – HIPH appears to be a great potential risk v reward trade…. We see 120 – 230%+ potential short term upside with less than a quarter of a penny downside.

American Premium Water (HIPH) produces domestic premium bottled water under the LALPINA brand name. LALPINA Natural High pH premium waters naturally hydrate, clear toxins and fortify your body against illness. Filtered naturally over thousands of years, bottled on site in both glass and PET containers, LALPINA Natural High pH waters, according to the Company, are likely to be the cleanest and best tasting you’ll ever encounter. . 

LALPINA WATER is sourced from a high-altitude aquifer deep in two locations, the Blue Ridge and the Blue Mountains. It is currently available in 7.3, 8.0 and 9.5 pH, either natural spring or sparkling, and in both 1-liter and 16 ounce glass bottles. The Company also recently announced a test run of its 7.3. pH water in PET/plastic.

You can check out their website at http://www.lalpinawater.com/ for more information

The strong relative volume that has come into HIPH recently is especially encouraging and appears to be a result of the Street taking notice of some major PR coming out of HIPH.

For example, HIPH announced in June that they expect a 530% increase in sales by the Fall/Winter of 2016. According to the press release, sales forecast continue to soar steadily due to a steady incline in orders of both its original glass and roll out of its new PET bottles.

HIPH unveiled their multi-faceted sales initiative to support self-distribution in U.S. markets and project and anticipate one million bottles++ in sales by Fall/Winter of 2016. Increased profitability through direct to consumer and wholesale distribution will significantly reduce costs while increasing the LALPINA brand said Chairman and CEO, naturalist, Al Culbreth.

This follows on from a previous announcement that HIPH, a producer of premium natural high pH water, has launched its new natural high pH water in PET. The company expanded its portfolio of bottled water responding directly to growing online consumer and retail demand for its best-selling 7.3 pH alkaline water in PET as well as its signature glass bottles, thereby giving consumers the option of container type for the first time.

 

The Massive Bottled Water Industry

The sales of bottled water increased 6.4 percent to top $15 billion in 2015, Chicago based market research firm, Mintel, expects sales to continue ascending at a rapid pace through 2020, with projected sales growth of 34.7 percent for the category, including 75.1 percent growth for the sparkling/mineral water/seltzer segment.

According to this Wall Street Journal article, retail sales of bottled water totaled $18.82 billion last year, an increase of 7%. That puts it on track to outsell soda by 2017, according to forecasts by industry tracker Beverage Marketing Corp.

Just imagine if you’d invested in Smart Water in the late 1990’s. A few years later it was purchased by Coco-Cola for over $4 Billion.

Can HIPH capitalize on this massive growth industry

With the innovative marketing approach, which utilizes celebrity marketing and product placement, we think they may just be on the right track.
 

According to this recent press release, HIPH has landed on the big screen with a placement in the new film “American Satan” starring Denise Richards, Malcolm McDowell and John Bradley (from “Game of Thrones”).

And HIPH has entered into a long-term strategic alliance with Beverly Hills-based motion picture production company Jeff Rice Films for product placement, branding, and joint venture initiatives.

But it doesn’t stop there. Lalpina water appears to be a celebrity and pro athlete favorite. The company uses celebrity marketing and branding as a cornerstone of growing brand awareness and to grow sales. Images online show fans of the water include Wayne Newton, Flo Rida, Kendra Wilkinson, Lance Bass, Lil’ Jon, William H Macy, JR Smith of NBA Champs Cleveland Cavaliers, Nick Cannon, Joe Manganiello and Kellan Lutz, Mario Lopez, Christina Milian and even featured in a Nascar event.

Former supermodel Elle McPherson was quoted in this Vogue Magazine article as saying “Try to keep your system alkaline. L’Alpina does a great alkaline water”.

Just do a Google Image search of “L’alpina water” and you will see so many celebrities drinking and endorsing Lalpina water. 

HIPH has also previously been featured on ABC News, Huffington Post, E Online, Dailymail UK and thousands of blogs and websites.

So we’ve touched on the technical bounce play trading opportunity and the major opportunities for HIPH in a massively growing market. We also note the company issued this important press release…

The CEO of American Premium Water Corp (HIPH) Announces Full Reporting Update

According to the press release, the Company has engaged an auditor and CPA to file its Form 10 with the SEC and move onto a fully reporting tier.

“I am very excited that we are taking the next steps in bringing our shareholders a successful company. Success is not measured by how much press you can put out but in how much you do for your shareholders and their investment. This summer we will have some groundbreaking and exciting updates for the public. APWC is about optimum health and quality of Life. And because we’re public, that means the health of our shareholders as well,” said CEO Alfred Culbreth.

We think given the exciting product development and growth opportunities, the pullback in price to very attractive levels, and the steps HIPH have taken to become a shareholder friendly company and attract new investors, we think HIPH could be a great trade for the short and long term.

We think there is the potential for short -medium term upside of between 120 – 230% if HIPH can regain its 50 or 100 day moving average. Of course we would really love to see a technical breakout past its recent highs of $0.04, in which case we could see some serious gains made.

The 52 week high is $0.10, so there could be the potential for medium to longer term upside. A move back to this level would be a 700%+ move. This may seem like a pipe dream, but the market is crazy right now. There are 200, 400 even 1,000% gains being made almost every day it seems.

Can HIPH be the next? We’ll find out soon. Be ready and don’t be late for the opening bell.

 
The Team
 
Click Below to Join Our Social Media Networks
 
     

 
—————————————————————————————————- DISCLAIMER ——————————————————————————————————
 
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
 Before buying or selling any pick featured in this newsletter you must read our full disclaimer can be read here

Pennystockgeneral.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever.

The disclaimer is to be read and fully understood before using our site, or joining our email list.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein.  Instead Pennystockgeneral.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Pennystockgeneral.com does not offer such advice or analysis, and Pennystockgeneral.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, Pennystockgeneral.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Pennystockgeneral.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Pennystockgeneral.com is not responsible for any claims made by the companies advertised herein.

Pennystockgeneral.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in Pennystockgeneral.com statements and opinions and such statements and opinions cannot be considered independent. Pennystockgeneral.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, Pennystockgeneral .com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. Pennystockgeneral.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. Pennystockgeneral.com has been compensated up to two thousand dollars via wire transfer or electronic payment from a non-affiliated third party for this profile of HIPH
 
Pennystockgeneral.com may on occasion accept compensation in restricted or free-trading shares for it’s marketing services of the company being profiled, and the third party that might have compensated Pennystockgeneral.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.  If Pennystockgeneral.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services.